Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc.
IRWD
Valuace
18
Růst
63
Zdraví
50
Cena
$ 2.50
Dnes
--0.02 (-0.44%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.4B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-51%
ROA
7%
PE
23
PS
2
Cena 1R
1-6
⌀ Cena
1.64
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

Ironwood Pharmaceuticals, Inc., zdravotní společnost, se zaměřuje na vývoj a komercializaci gastrointestinálních (GI) produktů. Prodává linaclotid, agonistu guanylátcyklázy typu C k léčbě dospělých pacientů trpících syndromem dráždivého střeva se zácpou (IBS-C) nebo chronickou idiopatickou zácpou (CIC) pod názvem LINZESS ve Spojených státech a Mexiku, stejně jako pod názvem CONSTELLA v Kanadě a Evropské unii. Společnost také vyvíjí IW-3300, agonistu GC-C pro léčbu viscerálních bolestí, včetně intersticiální cystitidy/syndromu bolesti močového měchýře a endometriózy, a CNP-104, imunitní nanočástici pro léčbu biliární cholangitidy. Společnost má strategická partnerství s AbbVie Inc., AstraZeneca AB a Astellas Pharma Inc. pro vývoj a komercializaci linaklotidu. Společnost byla dříve známá jako Microbia, Inc. a v dubnu 2008 změnila svůj název na Ironwood Pharmaceuticals, Inc. Ironwood Pharmaceuticals, Inc. byla založena v roce 1998 a sídlí v Bostonu v Massachusetts.
Sektor
Healthcare
Odvětví
Drug Manufacturers - Specialty & Generic
Počet zaměstnanců
253
Založení
2010-02-03
Adresa
100 Summer Street
CEO
Thomas A. McCourt
Web
www.ironwoodpharma.com

Podobné společnosti

CGC
Canopy Growth Corporation
$ 1.23
+ $ 0.06
LFCR
Lifecore Biomedical, Inc.
$ 7.10
+ $ 0.25
ACB
Aurora Cannabis Inc.
$ 4.61
+ $ 0.06
GNLX
Genelux Corporation
$ 5.94
+ $ 0.52
NPCE
NeuroPace, Inc.
$ 13.56
+ $ 0.44
ALDX
Aldeyra Therapeutics, Inc.
$ 4.77
+ $ 0.08
SLN
Silence Therapeutics plc
$ 6.62
+ $ 0.04

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues296.2296.2351.4442.7410.6413.8389.5428.4346.6298.3274.0149.676.422.9150.265.943.9
Cost of Revenues27.91.97.61.60.00.03.123.932.819.41.90.025.67.21.00.00.0
Gross Profit268.3294.3343.9441.2410.6413.8386.4404.5313.9278.9272.1149.550.915.7149.365.943.9
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues47.7122.185.241.190.591.694.474.9117.6113.7
Cost of Revenues0.50.00.027.40.029.80.025.80.50.5
Gross Profit47.2122.185.213.790.561.894.449.1117.0113.2
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0116.144.370.488.1115.0166.5148.2139.5108.7101.9102.4113.586.177.5
Selling General & Admin Expenses0.00.00.0158.3116.0111.1140.0172.5241.3233.1173.3125.2118.3123.292.545.927.2
Depreciation & Amortization1.91.92.01.69.50.716.90.38.16.21.011.612.311.711.310.06.2
Total Operating Expenses170.0175.5250.71,283.4160.3181.5228.1287.5415.9387.6313.8234.0220.2267.7222.0132.0104.6
Operating Income98.3118.893.1-945.4250.3232.3142.9120.1-238.9-77.4-51.9-102.1-169.4-252.0-72.8-66.1-60.8
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.035.133.0
Selling General & Admin Expenses0.00.00.00.00.00.00.00.037.636.0
Depreciation & Amortization0.50.50.50.50.50.50.50.50.50.5
Total Operating Expenses40.746.639.942.859.136.169.438.072.669.0
Operating Income6.675.545.3-29.131.525.625.011.044.440.0
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income4.14.14.519.09.50.71.52.93.02.11.20.40.30.20.20.50.6
Interest Expense32.732.733.021.67.631.229.536.634.734.338.030.721.221.00.10.10.2
Other Expense-28.2-48.7-27.9-2.62.1-31.6-34.1-61.2-145.626.0-2.1-27.60.7-20.80.10.91.4
IBT70.070.065.2-948.1252.4200.7108.958.9-282.4-116.9-81.7-142.7-189.6-272.8-72.6-64.8-59.4
Income Tax Expense46.046.064.383.577.4-327.82.774.3-5.834.338.019.08.6-11.7-11.30.0-2.9
Net Income24.024.00.9-1,002.2175.1528.4106.2-15.3-282.4-116.9-81.7-142.7-189.6-272.8-72.6-64.9-53.0
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income1.50.90.80.90.81.21.41.21.21.7
Interest Expense7.98.48.48.18.99.47.57.28.49.8
Other Expense-6.1-7.5-7.5-7.2-7.5-8.3-6.1-6.1-7.2-8.1
IBT0.568.037.8-36.324.017.418.95.030.431.9
Income Tax Expense2.727.914.21.121.713.719.79.132.118.0
Net Income-2.340.123.6-37.42.33.6-0.9-4.2-1.115.3
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-6.45$1.13$3.26$0.67$-0.10$-1.85$-0.78$-0.56$-1.00$-1.39$-2.35$-0.68$-0.65$-0.59
EPS Diluted$0.00$0.00$0.00$-6.45$0.96$3.21$0.66$-0.10$-1.85$-0.78$-0.56$-1.00$-1.39$-2.35$-0.68$-0.65$-0.59
Shares Outstanding162.2162.2159.1155.4154.4162.2159.4156.0152.6149.0145.9142.2136.8115.9106.499.989.7
Diluted Shares Outstanding177.8177.8160.1155.4186.3164.4160.7156.0152.6149.0145.9142.2136.8115.9106.499.989.7
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.01$0.10
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.01$0.08
Shares Outstanding162.2162.2161.7161.0159.9159.7159.0157.7156.0155.9
Diluted Shares Outstanding177.8177.8161.7161.0160.4160.2159.0157.7156.0186.9
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents105.588.692.2656.2620.1362.6177.0173.2125.754.0261.374.375.5136.787.344.3
Short Term Investments0.00.00.00.00.00.00.00.095.7251.2178.1174.0122.131.576.7203.7
Total Cash & ST Investments105.588.692.2656.2620.1362.6177.0173.2221.4305.2439.4248.3197.6168.2164.0248.0
Accounts Receivable58.181.9129.1115.5114.0122.4117.281.082.264.954.525.83.21.50.72.9
Inventory0.00.00.01.30.00.00.60.00.71.10.05.022.16.70.0-239.9
Other Current Assets14.511.912.07.70.00.011.912.37.39.06.310.66.28.02.9248.0
Total Current Assets178.2182.4233.3780.6745.2495.8306.9266.4311.6380.2500.2289.7229.1184.4167.6259.1
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents140.492.9108.588.688.2105.5121.592.2110.2175.3
Short Term Investments0.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments140.492.9108.588.688.2105.5121.592.2110.2175.3
Accounts Receivable120.486.239.881.976.258.172.0129.1124.5119.0
Inventory0.00.00.00.00.00.00.00.00.80.8
Other Current Assets13.112.712.311.914.214.514.612.018.924.1
Total Current Assets273.8191.8160.6182.4178.6178.2208.2233.3253.6317.6
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment16.915.518.220.322.925.530.217.317.320.521.129.837.437.533.634.4
Goodwill0.00.00.00.00.00.80.80.80.80.80.00.00.00.00.00.0
Intangible Assets3.32.93.70.00.00.00.00.0159.9166.10.00.00.00.00.00.0
Long-Term Investments0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets4.35.93.615.925.537.164.947.6116.1142.297.814.012.57.97.87.9
Total Long-Term Assets217.4168.5237.8319.9381.763.495.965.6294.1329.6118.943.849.845.541.442.3
Total Assets395.6350.9471.11,100.51,126.9559.2402.7332.1605.7709.8619.1333.5279.0229.9209.0301.4
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment13.414.114.915.516.216.917.518.218.619.2
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets2.22.52.72.93.13.33.53.73.94.1
Long-Term Investments0.00.00.00.00.00.00.00.00.50.5
Other Long-Term Assets4.85.25.55.9191.64.33.43.63.83.9
Total Long-Term Assets122.2151.2166.6168.5210.9217.4230.6237.8270.5285.6
Total Assets396.1342.9327.2350.9389.5395.6438.8471.1524.1603.2
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable3.22.17.80.50.90.75.571.661.562.936.135.932.048.66.421.4
Short-Term Debt3.23.2202.73.1120.03.11.147.64.16.227.612.41.10.30.20.2
Other Current Liabilities38.231.064.322.01.30.533.40.10.214.25.55.02.82.722.20.0
Current Liabilities45.538.8276.125.5161.732.740.9119.566.091.176.560.541.054.965.164.4
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable1.61.45.82.13.23.26.27.84.73.5
Short-Term Debt3.2202.63.23.23.23.2202.9202.7202.4202.2
Other Current Liabilities237.726.837.331.043.038.239.564.372.293.1
Current Liabilities242.5232.548.138.849.445.5252.4276.1280.6305.4
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt623.6596.3512.9412.9355.8450.6430.1366.3396.1366.6353.9164.9177.80.30.40.4
Capital Leases13.515.517.719.721.623.423.20.24.16.32.93.74.30.60.70.6
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.081.7-2.68.811.6-0.4-14.6
Total Liabilities717.3652.2817.4448.1521.0496.6496.0528.4595.8643.1524.0245.0240.785.999.1141.8
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt210.0396.1595.9596.3611.7637.1487.5512.9538.2613.6
Capital Leases13.714.30.015.516.113.517.114.518.218.7
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities452.5651.1661.3652.2700.9717.3769.3817.4849.7950.0
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.20.20.20.20.20.20.20.20.20.10.10.10.10.10.10.1
Retained Earnings-1,703.6-1,697.7-1,698.6-696.4-937.6-1,466.1-1,572.2-1,591.1-1,308.8-1,191.8-1,110.1-967.4-777.8-505.0-432.4-367.5
Comprehensive Income-0.50.9-3.00.00.00.00.00.0-0.10.0-0.10.00.00.00.00.0
Total Common Equity-321.7-301.3-346.3652.4605.962.6-93.3-196.49.866.795.188.638.2144.1109.9159.6
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.20.20.20.20.20.20.20.20.20.2
Retained Earnings-1,671.4-1,711.5-1,735.1-1,697.7-1,700.0-1,703.6-1,702.8-1,698.6-1,697.5-1,712.8
Comprehensive Income-1.7-2.00.30.9-2.1-0.5-0.9-3.0-0.80.0
Total Common Equity-56.4-308.2-334.1-301.3-311.3-321.7-330.5-346.3-325.7-346.8
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt640.3599.5715.5415.9475.8453.7431.2413.9400.2372.8381.5177.3178.90.60.70.6
Book Value-321.7-301.3-346.3652.4605.962.6-93.3-196.49.866.795.188.638.2144.1109.9159.6
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.0-2.5-1.1
Book Value-56.4-308.2-334.1-301.3-311.3-321.7-330.5-346.3-325.7-346.8
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income7.824.00.9-1,002.2175.1528.4106.221.5-282.4-116.9-81.7-142.7-189.6-272.8-72.6-64.9-56.4
Depreciation & Amortization2.01.92.01.61.41.53.65.614.214.611.311.612.311.711.310.06.2
Stock-Based Compensation33.617.329.932.027.022.331.231.344.033.829.225.526.219.817.611.77.5
Change Working Capital31.739.70.711.32.817.7-0.9-100.07.6-21.8-5.0-38.2-30.1-35.7-27.1-34.4-21.3
Change In Accounts Receivable60.935.147.20.98.07.74.1-68.91.2-17.3-10.3-28.7-23.7-1.7-0.82.22.3
Change In Accounts Payable-20.56.2-20.212.4-8.1-2.6-7.5-32.78.1-6.819.7-1.61.4-11.724.25.12.7
Change In Inventories0.00.00.00.00.00.00.60.7-0.80.31.33.7-3.1-11.9-6.71.3-9.3
Other Non-cash Items-30.83.42.01,068.21.725.222.316.4-13.4-16.828.18.44.11.71.22.21.6
Cash from Operations146.70.00.0183.4273.8261.9168.810.7-70.9-99.6-25.4-106.9-155.6-273.4-69.6-75.2-67.9
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income61.440.123.6-37.43.23.6-0.9-4.2-1.114.0
Depreciation & Amortization1.40.50.50.50.50.50.50.50.50.5
Stock-Based Compensation12.03.64.55.30.08.38.68.48.77.9
Change Working Capital73.5-25.2-58.750.1-33.6-10.611.433.6-8.5-4.7
Change In Accounts Receivable73.6-34.2-46.442.1-5.7-18.113.957.1-4.6-5.6
Change In Accounts Payable-0.310.7-13.89.7-5.80.1-2.0-12.5-12.56.6
Change In Inventories0.00.00.00.00.00.00.00.00.00.0
Other Non-cash Items-113.80.90.90.84.00.40.60.64.90.6
Cash from Operations0.00.00.00.00.00.00.00.035.832.5
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.40.0-0.1-0.3-0.1-0.3-1.8-7.2-8.6-4.2-104.2-4.0-3.5-9.6-14.0-9.7-17.2
Acquisitions-26.60.00.0-1,026.00.00.00.00.00.00.0100.00.00.00.00.00.09.5
Investments0.00.00.00.00.00.00.00.0-3.2-191.4-311.1-282.0-254.0-287.9-96.7-97.5-441.8
Sales of Investment0.00.00.00.00.00.00.00.099.2346.9237.4276.7201.0196.1140.8222.3236.5
Other Investing Activities-22.70.00.00.00.00.00.0-4.01.60.1-99.80.10.00.00.00.00.0
Cash from Investing-26.90.00.0-1,026.3-0.1-0.3-1.8-11.188.9151.5-177.7-9.2-56.6-101.430.1115.1-213.0
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00.00.00.00.00.0-0.1-0.1-0.20.0
Acquisitions0.00.00.00.00.00.00.00.0-4.0-22.6
Investments0.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.00.0-22.6
Cash from Investing0.00.00.00.00.00.00.00.0-4.2-22.6
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-172.70.00.0300.0-120.70.00.0-156.4-1.8-137.5-28.8-14.0-2.2-0.8-0.3-0.3-2.0
Debt Issued-2.8599.5-116.1599.660.822.122.5173.715.6164.920.1218.20.6179.10.20.32.5
Issuance of Common Stock11.80.00.06.49.50.00.00.00.00.00.00.0190.4137.885.20.0203.2
Repurchase of Common Stock-0.60.00.00.0-126.4-24.10.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.0-111.20.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities-104.90.00.0-22.8111.219.618.5155.231.9157.324.6317.122.7176.64.03.41.7
Cash from Financing-190.80.00.0277.2-237.6-4.618.5-1.230.119.8-4.2303.1210.9313.689.03.1203.0
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-22.7-75.0
Debt Issued213.2-385.4-0.4-0.4-15.4-25.4-50.2-25.1-2.4-0.1
Issuance of Common Stock0.00.00.00.00.00.00.00.01.00.0
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-28.20.0
Cash from Financing0.00.00.00.00.00.00.00.0-50.9-75.0
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-70.6126.9-3.6-565.836.1257.1185.5-1.648.171.7-207.3187.0-1.2-61.249.443.0-78.0
Closing Cash Balance105.5215.588.692.2657.9621.9364.8179.2180.8125.754.0261.374.375.5136.787.344.3
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash75.047.6-15.619.90.3-17.3-16.029.4-18.8-65.2
Closing Cash Balance215.5140.492.9108.588.688.2105.5121.592.2111.5
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow146.4127.0103.4183.2273.6261.6167.03.5-79.5-103.8-129.6-111.0-159.1-282.9-83.6-84.9-85.1
Real Free Cash Flow112.8109.873.6151.1246.6239.3135.8-27.7-123.5-137.6-158.9-136.4-185.3-302.8-101.2-96.7-92.6
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow74.647.6-15.119.915.29.933.444.935.632.4
Real Free Cash Flow62.644.0-19.614.615.21.524.836.526.924.5
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E22.5-5.32356.8
P/S1.81570.5
P/B-9.618.72015.4
P/FCF5.3-6.27573.5
Market cap$0.4$1.1
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets53.8 %65.1 %0 %
Debt to Income887.9 %-16.5 %0 %
Debt to Free cash flow209.8 %-2438 %0 %
Interest expense percentage33.3 %-3.7 %26.2 %
Current ratio1.1 6.7 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-42.5 %-42.8 %0 %
ROA6.1 %-28.6 %0 %
CapEx to Revenue0 %10.4 %6 %
RaD to Revenue0 %100 %0 %
ROEM1,170,557.3 711184.8

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin91.9 %93.8 %74.8 %
Operating margin36.3 %-100.2 %35 %
Net margin8.4 %-109.3 %34.1 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding177.8 mil 141.1 mil
Employee count0.3 tis 0.4 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader